|
Volumn 9, Issue 5, 2005, Pages 351-357
|
New practice parameters: What does the evidence say?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMITRIPTYLINE;
CLONIDINE;
CYPROHEPTADINE;
ETIRACETAM;
FLUNARIZINE;
IBUPROFEN;
NIMODIPINE;
PARACETAMOL;
PIZOTIFEN;
PLACEBO;
PROPRANOLOL;
RIZATRIPTAN;
SUMATRIPTAN;
TOPIRAMATE;
TRAZODONE;
VALPROATE SEMISODIUM;
ZOLMITRIPTAN;
CHILD;
CHILDHOOD DISEASE;
CLINICAL PRACTICE;
CLINICAL TRIAL;
COMORBIDITY;
COMPUTER ASSISTED TOMOGRAPHY;
CONSCIOUSNESS DISORDER;
DATA ANALYSIS;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
ELECTROENCEPHALOGRAPHY;
EVIDENCE BASED MEDICINE;
HEADACHE;
HUMAN;
INTRACRANIAL HYPERTENSION;
LABORATORY TEST;
MEDICAL PARAMETERS;
MEDICAL SOCIETY;
MIGRAINE;
MIGRAINE WITHOUT AURA;
NEUROIMAGING;
NEUROLOGIC DISEASE;
NEUROLOGIC EXAMINATION;
NEUROLOGY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PUBLICATION;
RECURRENT DISEASE;
REVIEW;
SEIZURE;
SIDE EFFECT;
|
EID: 26444480261
PISSN: 15313433
EISSN: None
Source Type: Journal
DOI: 10.1007/s11916-005-0012-9 Document Type: Review |
Times cited : (9)
|
References (9)
|